Based on the forecasted data, stomach malignant neoplasms mortality in the US is stable from 2024 to 2028, with the rate per 100,000 persons remaining between 3.0 and 3.1. There is no significant year-on-year variation, indicating a steady state of mortality rates during this period.

Future trends to watch for include the impact of advances in medical technology, lifestyle changes, and early detection programs, which may alter mortality rates. Monitoring demographic shifts and healthcare policies will be crucial to understanding long-term changes in stomach cancer mortality. Additionally, emerging research into risk factors could influence future projections.

Download as XLS

More about Stomach Cancer Industry 2025-2029